US 12325691
Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain
granted A61KA61K31/496A61P
Quick answer
US patent 12325691 (Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain) held by The Board of Regents of the University of Texas System expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/496, A61P, A61P25/00, A61P25/28